Citations (70)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Stacey C. Sigmon, Adam Bisaga, Edward V. Nunes, Patrick G. O'Connor, Thomas Kosten & George Woody. (2012) Opioid Detoxification and Naltrexone Induction Strategies: Recommendations for Clinical Practice. The American Journal of Drug and Alcohol Abuse 38:3, pages 187-199.
Read now
Read now
Amy Wachholtz, Douglas Ziedonis & Gerardo Gonzalez. (2011) Comorbid Pain and Opioid Addiction: Psychosocial and Pharmacological Treatments. Substance Use & Misuse 46:12, pages 1536-1552.
Read now
Read now
Colin N. Haile, Thomas R. Kosten & Therese A. Kosten. (2009) Pharmacogenetic Treatments for Drug Addiction: Cocaine, Amphetamine and Methamphetamine. The American Journal of Drug and Alcohol Abuse 35:3, pages 161-177.
Read now
Read now
Colin N. Haile, Therese A. Kosten & Thomas R. Kosten. (2008) Pharmacogenetic Treatments for Drug Addiction: Alcohol and Opiates. The American Journal of Drug and Alcohol Abuse 34:4, pages 355-381.
Read now
Read now
Kathleen Ang-Lee, MichaelR. Oreskovich, AndrewJ. Saxon, Craig Jaffe, Charles Meredith, Mei
Ling K. Ellis, CarolA. Malte & PatriciaC. Knox. (2006) Single Dose of 24 Milligrams of Buprenorphine for Heroin Detoxification: An Open-label Study of Five Inpatients. Journal of Psychoactive Drugs 38:4, pages 505-512.
Read now
Read now
Gerardo Gonzalez, Alison Oliveto & Thomas R Kosten. (2004) Combating opiate dependence: a comparison among the available pharmacological options. Expert Opinion on Pharmacotherapy 5:4, pages 713-725.
Read now
Read now
DavidC. Lewis. (1999) Access to Narcotic Addiction Treatment and Medical Care. Journal of Addictive Diseases 18:2, pages 5-21.
Read now
Read now
. (1999) Effective Medical Treatment of Opiate Addiction. Journal of Pharmaceutical Care in Pain & Symptom Control 7:3, pages 61-82.
Read now
Read now
Peggy A. Compton, Donald R. Wesson, V. Charles Charuvastra & Walter Ling. (1996) Buprenorphine as a Pharmacotherapy for Opiate Addiction What Dose Provides a Therapeutic Response?. American Journal on Addictions 5:3, pages 220-230.
Read now
Read now
Walter Ling, RichardA. Rawson & MargaretA. Compton. (1994) Substitution Pharmacotherapies for Opioid Addiction: From Methadone to LAAM and Buprenorphine. Journal of Psychoactive Drugs 26:2, pages 119-128.
Read now
Read now
Theodore V. Parran, Christopher L. Adelman & Donald R. Jasinski. (1994) A Buprenorphine Stabilization and Rapid-Taper Protocol for the Detoxification of Opioid-Dependent Patients. American Journal on Addictions 3:4, pages 306-313.
Read now
Read now
Nancy K. Mello, Jack H. Mendelson, Scott E. Lukas, David R. Gastfriend, Siew Koon Teoh & B. Leonard Holman. (1993) Buprenorphine Treatment of Opiate and Cocaine Abuse: Clinical and Preclinical Studies. Harvard Review of Psychiatry 1:3, pages 168-183.
Read now
Read now
Macdonald J. Christie & Anna I. Harvey. (1993) Pharmacological options for management of opioid dependence. Drug and Alcohol Review 12:1, pages 71-80.
Read now
Read now
Articles from other publishers (57)
Meng-Chang Tsai, Chia-Ru Chung, Chun-Chuan Chen, Jyun-Yu Chen, Shih-Ching Yeh, Chun-Han Lin, Ying-Ju Chen, Ming-Che Tsai, Ya-Ling Wang, Chia-Ju Lin & Eric Hsiao-Kuang Wu. (2021) An Intelligent Virtual-Reality System With Multi-Model Sensing for Cue-Elicited Craving in Patients With Methamphetamine Use Disorder. IEEE Transactions on Biomedical Engineering 68:7, pages 2270-2280.
Crossref
Crossref
Walter Ling & Steve Shoptaw. 2021. Treating Opioid Use Disorder in General Medical Settings. Treating Opioid Use Disorder in General Medical Settings
9
21
.
Thomas GeschwindeThomas Geschwinde. 2018. Rauschdrogen. Rauschdrogen
791
1000
.
Linda Gowing, Robert Ali, Jason M White & Dalitso Mbewe. (2017) Buprenorphine for managing opioid withdrawal. Cochrane Database of Systematic Reviews 2017:2.
Crossref
Crossref
Carmen Walter, Claudia Knothe & Jörn Lötsch. (2015) Abuse-Deterrent Opioid Formulations: Pharmacokinetic and Pharmacodynamic Considerations. Clinical Pharmacokinetics 55:7, pages 751-767.
Crossref
Crossref
Mark K. Greenwald, Sandra D. Comer & David A. Fiellin. (2014) Buprenorphine maintenance and mu-opioid receptor availability in the treatment of opioid use disorder: Implications for clinical use and policy. Drug and Alcohol Dependence 144, pages 1-11.
Crossref
Crossref
Thomas GeschwindeThomas Geschwinde. 2013. Rauschdrogen. Rauschdrogen
647
830
.
Norbert Scherbaum & Markus Gastpar. 2012. Handbuch der Psychopharmakotherapie. Handbuch der Psychopharmakotherapie
885
896
.
Frederick L Altice, R Douglas Bruce, Gregory M Lucas, Paula J Lum, P Todd Korthuis, Timothy P Flanigan, Chinazo O Cunningham, Lynn E Sullivan, Pamela Vergara-Rodriguez, David A Fiellin, Adan Cajina, Michael Botsko, Vijay Nandi, Marc N Gourevitch & Ruth Finkelstein. (2011) HIV Treatment Outcomes Among HIV-Infected, Opioid-Dependent Patients Receiving Buprenorphine/Naloxone Treatment within HIV Clinical Care Settings: Results From a Multisite Study. JAIDS Journal of Acquired Immune Deficiency Syndromes 56:Supplement 1, pages S22-S32.
Crossref
Crossref
Gerardo González & Mauricio Romero-González. (2010) Alternativas farmacológicas para el tratamiento de la dependencia a la heroína: un nuevo reto en Colombia. Revista Colombiana de Psiquiatría 39, pages 188S-212S.
Crossref
Crossref
Colin N Haile & Thomas R Kosten. (2009) The potential of pharmacogenomics to treat drug addiction. Pharmacogenomics 10:12, pages 1883-1886.
Crossref
Crossref
Linda Gowing, Robert Ali & Jason M White. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Stacey C. Sigmon, Kelly E. Dunn, Gary J. Badger, Sarah H. Heil & Stephen T. Higgins. (2009) Brief buprenorphine detoxification for the treatment of prescription opioid dependence: A pilot study. Addictive Behaviors 34:3, pages 304-311.
Crossref
Crossref
Shih-Ku Lin, Chia-Hui Chen & Chun-Hung Pan. (2008) Venlafaxine for Acute Heroin Detoxification. Journal of Clinical Psychopharmacology 28:2, pages 189-194.
Crossref
Crossref
Sandra D Comer, Maria A Sullivan, Robert A Whittington, Suzanne K Vosburg & William J Kowalczyk. (2007) Abuse Liability of Prescription Opioids Compared to Heroin in Morphine-Maintained Heroin Abusers. Neuropsychopharmacology 33:5, pages 1179-1191.
Crossref
Crossref
. 2007. Rauschdrogen. Rauschdrogen
603
762
.
Frederick L. Altice, Lynn E. Sullivan, Duncan Smith-Rohrberg, Sanjay Basu, Sharon Stancliff & Lois Eldred. (2006) The Potential Role of Buprenorphine in the Treatment of Opioid Dependence in HIV-Infected Individuals and in HIV Infection Prevention. Clinical Infectious Diseases 43:Supplement_4, pages S178-S183.
Crossref
Crossref
Hortensia Amaro, Sandra Arévalo, Gerardo Gonzalez, José Szapocznik & Martin Y. Iguchi. (2006) Needs and scientific opportunities for research on substance abuse treatment among Hispanic adults. Drug and Alcohol Dependence 84, pages S64-S75.
Crossref
Crossref
Linda Gowing, Robert Ali & Jason M White. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Domenic A. Ciraulo, Robert J. Hitzemann, Eugene Somoza, Clifford M. Knapp, John Rotrosen, Ofra Sarid-Segal, Ann Marie Ciraulo, David J. Greenblatt & C. Nora Chiang. (2006) Pharmacokinetics and Pharmacodynamics of Multiple Sublingual Buprenorphine Tablets in Dose-Escalation Trials. The Journal of Clinical Pharmacology 46:2, pages 179-192.
Crossref
Crossref
J Seifert, C Metzner, W Paetzold, M Borsutzky, M Ohlmeier, T Passie, U Hauser, H Becker, B Wiese, HM Emrich & U Schneider. (2005) Mood and affect during detoxification of opiate addicts: a comparison of buprenorphine versus methadone. Addiction Biology 10:2, pages 157-164.
Crossref
Crossref
Dima Rozen, Carson Ling & Cris Schade. (2005) Coadministration of an Opioid Agonist and Antagonist for Pain Control. Pain Practice 5:1, pages 11-17.
Crossref
Crossref
Michael R. Oreskovich, Andrew J. Saxon, Mei Ling K. Ellis, Carol A. Malte, Joseph P. Reoux & Patricia C. Knox. (2005) A double-blind, double-dummy, randomized, prospective pilot study of the partial Mu opiate agonist, buprenorphine, for acute detoxification from heroin. Drug and Alcohol Dependence 77:1, pages 71-79.
Crossref
Crossref
Fergus D. Law, Judy S. Myles, Mark R. C. Daglish & David J. Nutt. (2014) The clinical use of buprenorphine in opiate addiction: evidence and practice. Acta Neuropsychiatrica 16:5, pages 246-274.
Crossref
Crossref
Katharine P. Bailey. (2004) Pharmacological Treatments for Substance Use Disorders. Journal of Psychosocial Nursing and Mental Health Services 42:8, pages 14-20.
Crossref
Crossref
Enno FreyeEnno Freye. 2004. Opioide in der Medizin. Opioide in der Medizin
371
377
.
Enno FreyeEnno Freye. 2004. Opioide in der Medizin. Opioide in der Medizin
357
370
.
Enno FreyeEnno Freye. 2004. Opioide in der Medizin. Opioide in der Medizin
325
356
.
Enno FreyeEnno Freye. 2004. Opioide in der Medizin. Opioide in der Medizin
323
324
.
Enno FreyeEnno Freye. 2004. Opioide in der Medizin. Opioide in der Medizin
311
322
.
Wenjiang Zhang, Yamini Ramamoorthy, Rachel F. Tyndale & Edward M. Sellers. (2003) INTERACTION OF BUPRENORPHINE AND ITS METABOLITE NORBUPRENORPHINE WITH CYTOCHROMES P450 IN VITRO. Drug Metabolism and Disposition 31:6, pages 768-772.
Crossref
Crossref
Devang H. Gandhi, Jerome H. Jaffe, Scot McNary, Greg J. Kavanagh, Michael Hayes & Marian Currens. (2003) Short‐term outcomes after brief ambulatory opioid detoxification with buprenorphine in young heroin users. Addiction 98:4, pages 453-462.
Crossref
Crossref
M.D. Baño rodrigo. (2003) Tratamiento de sustitución con buprenorfina (Subutex®): modelo de aplicación de una experiencia piloto en la Comunidad de Madrid. Trastornos Adictivos 5:4, pages 303-308.
Crossref
Crossref
Thomas GeschwindeThomas Geschwinde. 2003. Rauschdrogen. Rauschdrogen
511
641
.
Gerardo Gonzalez, Alison Oliveto & Thomas R. Kosten. (2002) Treatment of Heroin (Diamorphine) Addiction. Drugs 62:9, pages 1331-1343.
Crossref
Crossref
Debra S Harris, Reese T Jones, Susette Welm, Robert A Upton, Emil Lin & John Mendelson. (2000) Buprenorphine and naloxone co-administration in opiate-dependent patients stabilized on sublingual buprenorphine. Drug and Alcohol Dependence 61:1, pages 85-94.
Crossref
Crossref
Irene Kuo, Benedikt Fischer & David Vlahov. (2000) Consideration of a North American heroin-assisted clinical trial for the treatment of opiate-dependent individuals. International Journal of Drug Policy 11:5, pages 357-370.
Crossref
Crossref
KEVIN A. SEVARINO, ALISON OLIVETO & THOMAS R. KOSTEN. (2006) Neurobiological Adaptations to Psychostimulants and Opiates as a Basis of Treatment Development. Annals of the New York Academy of Sciences 909:1, pages 51-87.
Crossref
Crossref
U. Schneider, W. Paetzold, V. Eronat, T. J. Huber, J. Seifert, B. Wiese & H. M. Emrich. (2006) Buprenorphine and carbamazepine as a treatment for detoxification of opiate addicts with multiple drug misuse: a pilot study. Addiction Biology 5:1, pages 65-69.
Crossref
Crossref
Kory J Schuh & Chris-Ellyn Johanson. (1999) Pharmacokinetic comparison of the buprenorphine sublingual liquid and tablet. Drug and Alcohol Dependence 56:1, pages 55-60.
Crossref
Crossref
John Mendelson, Reese T. Jones, Susette Welm, James Brown & Steven L. Batki. (1997) Buprenorphine and naloxone interactions in methadone maintenance patients. Biological Psychiatry 41:11, pages 1095-1101.
Crossref
Crossref
Thomas Eissenberg, Rolley E. Johnson, George E. Bigelow, Sharon L. Walsh, Ira A. Liebson, Eric C. Strain & Maxine L. Stitzer. (1997) Controlled opioid withdrawal evaluation during 72 h dose omission in buprenorphine-maintained patients. Drug and Alcohol Dependence 45:1-2, pages 81-91.
Crossref
Crossref
Elena M. Kouri, Scott E. Lukas & Jack H. Mendelson. (1996) P300 assessment of opiate and cocaine users: Effects of detoxification and buprenorphine treatment. Biological Psychiatry 40:7, pages 617-628.
Crossref
Crossref
Peggy A. Compton, Donald R. Wesson, V. Charles Charuvastra & Walter Ling. (2010)
Buprenorphine as a Pharmacotherapy for Opiate Addiction:
What Dose Provides a Therapeutic Response?
. The American Journal on Addictions 5:3, pages 220-230.
Crossref
Crossref
John Mendelson, Reese T. Jones, Isabella Fernandez, Susette Welm, Ann K. Melby & Matthew J. Baggott. (1996) Buprenorphine and naloxone interactions in opiate-dependent volunteers*. Clinical Pharmacology & Therapeutics 60:1, pages 105-114.
Crossref
Crossref
Ivan D. Montoya, Annie Umbricht & Kenzie L. Preston. (1995) Buprenorphine for human immunovirus-positive opiate-dependent patients. Biological Psychiatry 38:2, pages 135-136.
Crossref
Crossref
Marc A. SchuckitMarc A. Schuckit. 1995. Drug and Alcohol Abuse. Drug and Alcohol Abuse
303
349
.
Christopher H. van Dyck, Marc I. Rosen, H.Mikel Thomas, Thomas J. McMahon, Elizabeth A. Wallace, Patrick G. O'Connor, Michelle Sullivan, John H. Krystal, Paul B. Hoffer, Scott W. Woods & Thomas R. Kosten. (1994) SPECT regional cerebral blood flow alterations in naltrexone-precipitated withdrawal from buprenorphine. Psychiatry Research: Neuroimaging 55:4, pages 181-191.
Crossref
Crossref
Theodore V. Parran, Christopher L. Adelman & Donald R. Jasinski. (2010) A Buprenorphine Stabilization and Rapid‐Taper Protocol for the Detoxification of Opioid‐Dependent Patients. The American Journal on Addictions 3:4, pages 306-313.
Crossref
Crossref
Luigi Janiri, Paolo Mannelli, Antonio M. Persico, Alessandro Serretti & Enrico Tempesta. (1994) Opiate detoxification of methadone maintenance patients using lefetamine, clonidine and buprenorphine. Drug and Alcohol Dependence 36:2, pages 139-145.
Crossref
Crossref
Lawrence J. Cheskin, Paul J. Fudala & Rolley E. Johnson. (1994) A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids. Drug and Alcohol Dependence 36:2, pages 115-121.
Crossref
Crossref
Juan José Legarda & Michael Gossop. (1994) A 24-h inpatient detoxification treatment for heroin addicts: a preliminary investigation. Drug and Alcohol Dependence 35:2, pages 91-93.
Crossref
Crossref
Peter Banys, H.Westley Clark, Donald J. Tusel, Karen Sees, Pablo Stewart, Lou Mongan, Kevin Delucchi & Enoch Callaway. (1994) An open trial of low dose buprenorphine in treating methadone withdrawal. Journal of Substance Abuse Treatment 11:1, pages 9-15.
Crossref
Crossref
Richard S. Schottenfeld, Juliana Pakes, Douglas Ziedonis & Thomas R. Kosten. (1993) Buprenorphine: Dose-related effects on cocaine and opioid use in cocaine-abusing opioid-dependent humans. Biological Psychiatry 34:1-2, pages 66-74.
Crossref
Crossref
David A. Gorelick. (1993) Overview of Pharmacologic Treatment Approaches for Alcohol and Other Drug Addiction: Intoxication, Withdrawal, and Relapse Prevention. Psychiatric Clinics of North America 16:1, pages 141-156.
Crossref
Crossref
W. E. Platz, J. Böning, W. Wesemann, N. Weiner, A. Hartmann, J. Deckert & C. H. Gleiter. 1993. Neuro-Psychopharmaka. Neuro-Psychopharmaka
125
226
.
Marc I. Rosen & Thomas R. Kosten. 1992. Drug Abuse Treatment. Drug Abuse Treatment
137
147
.